Yale School of Medicine Neuroscientist receives Javits Award

September 20, 2005

New Haven, Conn.-Stephen Strittmatter, M.D., professor of neurology and neurobiology at Yale School of Medicine and an internationally recognized leader in developmental biology, is a 2005 recipient of the Javits Award.

The National Institute of Neurological Disorders and Stroke (NINDS) awards the funding to individual investigators who have demonstrated exceptional scientific excellence and productivity in research. The award guarantees funding to neuroscientists for up to seven years. It will enable Strittmatter, who has a particular expertise in axonal guidance and signal transduction, to further study signaling pathways and loss of function studies in animal models of disease.

"This award will provide substantial resources to continue our investigations of axon growth and guidance in the brain," Strittmatter said. "We are hopeful that insights gained from these studies will lead to novel therapeutic approaches to treat axonal dysfunction in a range of neurological disorders, including amyotrophic lateral sclerosis."

Findings resulting from Strittmatter's research may provide novel insight into how nervous system connectivity is assembled or misassembled during development and will aid in the design of therapies based on axonal growth and regeneration.

The Javits awards were instituted in 1983 in honor of U.S. Sen. Jacob Javits of New York, who was a strong advocate for research on a variety of neurological disorders. Javits suffered from amyotrophic lateral sclerosis, the disabling neurodegenerative disease also known as Lou Gehrig's disease.

"The Javits award gives highly productive scientists, whose work is on the cutting edge in their field, an even greater opportunity to understand the interplay involved in the cause and, hopefully, treatment or even prevention of neurological diseases," said NINDS Director Story Landis.

Strittmatter was one of six neuroscientists to receive the award this year.
-end-


Yale University

Related Amyotrophic Lateral Sclerosis Articles from Brightsurf:

Converting lateral scanning into axial focusing to speed up 3D microscopy
In optical microscopy, high-speed volumetric imaging is limited by either the slow axial scanning rate or aberrations introduced by the z-scanning mechanism.

Ammonium triggers formation of lateral roots
Despite the importance of changes in root architecture to exploit local nutrient patches, mechanisms integrating external nutrient signals into the root developmental program remain poorly understood.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Adjustable lordotic expandable vs static lateral lumbar interbody fusion devices
The objective of this study is to compare the clinical and radiographic outcomes between patients treated with static and expandable interbody spacers with adjustable lordosis for MIS LLIF.

Chirality-assisted lateral momentum transfer for bidirectional enantioselective separation
Chiral nanoparticles which twist the light were theoretically predicted to experience lateral forces perpendicular to light vector but lacks experimental verification.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

Researchers delay onset of amyotrophic lateral sclerosis (ALS) in laboratory models
Scientists have delayed the onset of amyotrophic lateral sclerosis (ALS) in laboratory models, leaving them cautiously optimistic that the result, combined with other clinical advances, points to a potential treatment for ALS in humans.

Emerging role of adenosine in brain disorders and amyotrophic lateral sclerosis
The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis (ALS).

New clues about the origins of familial forms of Amyotrophic lateral sclerosis
A Brazilian study made important progress in understanding the accumulation of one of the proteins involved in amyotrophic lateral sclerosis (ALS).

Recrutement of a lateral root developmental pathway into root nodule formation of legumes
Peas and other legumes develop spherical or cylindrical structures -- called nodules -- in their roots to establish a mutually beneficial relationship with bacteria that convert atmospheric nitrogen into a useable nutrient for the legume plant.

Read More: Amyotrophic Lateral Sclerosis News and Amyotrophic Lateral Sclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.